Cardurion Pharmaceuticals, Inc.

Biotechnology company · Burlington, Massachusetts, United States

Cardurion Pharmaceuticals, Inc. is a biotechnology company headquartered in Burlington, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $260 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Cardurion Pharmaceuticals at a glance

Typebiotechnology company

HeadquartersBurlington, Massachusetts, United States

Earliest incorporation on record2017

SEC CIK1702453

What does Cardurion Pharmaceuticals do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $260.4 million sold (2024).

Frequently asked questions about Cardurion Pharmaceuticals

Where is Cardurion Pharmaceuticals headquartered?

Cardurion Pharmaceuticals, Inc. is headquartered in Burlington, Massachusetts, United States.

What does Cardurion Pharmaceuticals do?

Cardurion Pharmaceuticals, Inc. is a biotechnology company.

When was Cardurion Pharmaceuticals founded?

The earliest incorporation on record for Cardurion Pharmaceuticals, Inc. is in 2017, according to public company registers.

Similar companies

Vericel CorpBurlington, Massachusetts, United States
Consano Bio, Inc.Burlington, Massachusetts, United States
CoreMap, Inc.Burlington, Massachusetts, United States
MakscientificBurlington, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences